NCT00292435 - Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI) | Biotech Hunter

Enrollment

202

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2006

Conditions

Venous Insufficiency

Interventions

DRUG

Read vine leaf extract (AS 195)

Trial Locations (16)

LKH Graz, Graz

AKH Wien, Vienna

VENEX Venenexperten, Vienna

Boehringer Ingelheim Investigational Site, Brno

Neurology-geriatric Institute, Moravský Beroun

Boehringer Ingelheim Investigational Site, Berlin

Klinik und Poliklinik der Universitat Bonn, Bonn

Boehringer Ingelheim Investigational Site, Cologne

Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

Klinik und Poliklinik fur Hautkrankheiten, Greifswald

Klinikum der Johannes Gutenberg-Universitat, Mainz

Gesundheitszentrum Minden, Minden

Boehringer Ingelheim Investigational Site, München

Boehringer Ingelheim Investigational Site, Oberkirch

Boehringer Ingelheim Investigational Site, Rottweil

Universitats-Hautklinik, Tübingen